295 research outputs found
Effect of Platelet-activating Factor on in vitro and in vivo Interleukin-6 Production
The aim of the present study was to investigate the possible effect
of platelet-activating factor (PAF), by comparison with
interleukin-1β and polyriboinositic/polyribocytidylic (poly
I–C) acid, on IL-6 production by L 929 mouse fibroblasts. At
concentrations above 1 μM PAF, the production of IL-6 by mouse
fibroblasts was enhanced in a dose dependent fashion. At 5 μM
PAF, the peak increase (60.1 ± 19.4 U/ml) was similar to
that induced by 50 μg/ml poly I–C (60.0 ± 35.0
U/ml) and higher than the one evoked by 100 U/ml IL-1β
(3.8 ± 1.8 U/ml). The increase of 11-6 activity induced
by 5 μM PAF was maximal after a 22 h incubation period with L 929
cells. Lyso-PAF (5 μM) also increased IL-6 activity from
fibroblasts to a similar extent compared with 5 μM PAF. In
addition, the IL-6 activity induced by 5 μM PAF was still
observed when the specific PAF antagonist, BN 52021 (10 μM), was
added to the incubation medium of L 929 cells. The result suggests
that the production of IL-6 by L 929 cells evoked by PAF in
vitro is not receptor mediated. The in vivo
effect of PAF on IL-6 production was also investigated in the rat.
Two hours after intravenous injection of PAF (2 to 4 μg/kg),
a dramatic increase of IL-6 activity in rat serum was observed, this
effect being dose dependent. The increase of IL-6 induced by 3
μg/kg PAF was not observed when the animals were treated with
the PAF antagonist, BN 52021 (1 to 60 mg/kg0. These results
demonstrate that PAF modulates IL-6 production and that the in
vivo effect is receptor mediated
Bronchial responses to substance P after antigen challenge in the guinea-pig: in vivo and in vitro studies
The effect of antigen challenge on the airway responses to substance P and on the epithelial neutral endopeptidase (NEP) activity was investigated in aerosol sensitized guinea-pigs. In vivo, bronchial responses to aerosolized substance P were similar to the responses observed in antigen-challenged guinea-pigs and in the control groups. In contrast, when the guinea-pigs were pretreated with the NEP inhibitor, phosphoramidon, a significant increase in the airway responses to substance P was observed after antigen challenge in vivo. However, in vitro, the contractile responses of the tracheal smooth muscle to substance P were similar between groups of guinea-pigs, in respect to the presence or absence of the epithelium and/or phosphoramidon. Histological studies showed an accumulation of eosinophils in the tracheal submucosa after antigen challenge and intact epithelial cells. These results show that in vivo bronchial hyperresponsiveness to substance P after antigen challenge in the guinea-pig is not associated with increased responses of the smooth muscle to exogenous SP in vitro. In addition, the results with phosphoramidon suggest that loss of NEP activity cannot account for the in vivo bronchial hyperresponsiveness to substance P presently observed
Bioassay-guided isolation of a potent platelet-activating factor antagonist alkenylresorcinol from Ardisia elliptica
In the course of our search for novel platelet-activating factor (PAF) antagonists from medicinal plants, the methanol extract of the leaves of Ardisia elliptica Thunb. was investigated for its inhibitory effects on PAF receptor binding to rabbit platelets using 3H-PAF as a ligand. The methanol extract showed inhibitory activity of 53.9% and its ethyl acetate, n-butanol, and methanol fractions exhibited 48.6%, 39.0%, and 22.0% inhibition, respectively. Bioassay-guided fractionation of the ethyl acetate fraction led to the isolation of a new alkenylresorcinol, 5-(Z-heptadec-4′-enyl)resorcinol, together with 5-pentadecylresorcinol. The alkenylresorcinol showed a strong inhibition with an IC50 value of 7.1 µM. The structures of the compounds were elucidated by spectroscopic techniques
Protective effect of PAF-acether antagonist, BN 52021, in trichothecen toxicosis
Trichothecenes are mycotoxins which produce Iethai toxicosis in humans and animals, yet no adequate therapeutic regimen has been developed. This study provides evidence that the selective platelet activating factor (PAF) antagonist, BN 52021 (5-15 mg/kg i.v.) can prolong the survival of conscious rats exposed to a highly Iethai T -2 toxicosis. These data also suggest that P AF is an important mediator of this unique toxicosis
Immune release of histamine and other lipid mediators from guinea-pig isolated kidney: antagonism by BN-52021
The ability of a specific PAF-receptor antagonist, BN-52021, to control the release of mediators of anaphylaxis from actively sensitized (ovalbumin) guinea-pig has been investigated "in vitro". BN-52021 perfused through the kidney at different molar concentrations (1 x 10(-4)-1 x 10(-5)-1 x 10(-6] prior to antigen challenge neither modified the basal values of perfusion pressure nor stimulated mediator release from the organ. On the contrary, the compound antagonized in a concentration dependent way both vasoconstriction of the renal vessels and the increase in the perfusate of histamine, TXB2 and SRS-A due to antigenic shock. The antagonistic activity of BN-52021 was very consistent at 1 x 10(-4) M at which concentration the immunological release of histamine and TXB2 was reduced by 75%. The beneficial effect of BN-52021 in experimental anaphylaxis of the kidney may have some therapeutic implications principally in those pathological conditions where an abnormal increase of renal histamine and other mediators may compromise the haemodynamic function of this organ
- …